Catalent Announces Governance Enhancements and New Initiatives to Drive Value

Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...

August 30, 2023 | Wednesday | News
Pyxis Oncology Successfully Completes Acquisition of Apexigen

Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as a leader in next-generation, end-to...

August 24, 2023 | Thursday | News
STARLIMS expands its R&D portfolio through the acquisition of Labstep

STARLIMS, a leading provider of enterprise informatics solutions, announces the expansion of its solution suite through the strategic acquisition of Labste...

August 23, 2023 | Wednesday | News
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with (i) an initial upfront consideration of $14 million, and (ii) up to an additional $...

August 22, 2023 | Tuesday | News
Bruker to Acquire PhenomeX in All-Cash Deal

Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire Pheno...

August 18, 2023 | Friday | News
TAE Life Sciences Partners with Biddle Sawyer for Cancer Treatment Drug

TAE Life Sciences has  announced a landmark agreement with Biddle Sawyer to serve as the exclusive supplier of TC220, a novel boronated amino aci...

August 16, 2023 | Wednesday | News
Gilead, Tentarix Partner to Develop Therapies for Cancer and Inflammation

– Collaboration Combines Gilead’s Oncology and Inflammation Expertise and Tentarix’s Tentacles™ Platform – – Gilead Re...

August 16, 2023 | Wednesday | News
Zetagen Raises $9.79M Series B for ZetaMet™ and ZetaMAST™ in Metastatic Lesion Treatment

ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently i...

August 14, 2023 | Monday | News
Novartis Completes Acquisition of Chinook Therapeutics

Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront Deal brings two phase 3 assets in d...

August 14, 2023 | Monday | News
Lilly Completes Acquisition of DICE Therapeutics

"Since our founding nearly 150 years ago, we've strived to make life better for people around the world – but we know that to achieve this goal, we h...

August 10, 2023 | Thursday | News
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

“We are pleased to announce the closing of this acquisition, as the brands we are adding will strengthen, complement and expand STERIS’s produc...

August 03, 2023 | Thursday | News
Guardant Settles Litigation with Illumina, Forges New Partnership for Cancer Research

he three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies, including any allegations related ...

August 02, 2023 | Wednesday | News
BioNTech Completes Acquisition of InstaDeep

Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design and development InstaDeep to opera...

August 01, 2023 | Tuesday | News
Sanofi Acquires Fast-Growing U.S. Brand Qunol® in Healthy Aging Segment.

Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...

July 31, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close